|
|
|
|
Genetic and Biochemical Characterization of TRU-1, the Endogenous Class C -Lactamase from Aeromonas enteropel
Aeromonas enteropelogenes (formerly A.tructi) was described to be an ampicillin-susceptible and cephalothin-resistant Aeromonas species, which suggests the production of a cephalosporinase. Strain ATCC 49803 was susceptible to amoxicillin, cefotaxime...
|
|
|
One-third of all prescriptions for children are antibiotics
Antibiotics are the most commonly prescribed drugs in Irish children, an RCSI study has found.The HRB Centre for Primary Care Research at the RCSI investigated the rate of antibiotic prescriptions among children in Ireland. Antibiotics represent one-third...
|
|
|
Middlebrook expands physician access to Moxatag samples
WESTLAKE, Texas MiddleBrook Pharmaceuticals Inc.is expanding its IncreaseRx promotion program for Moxatag amoxicillin extended-release tablets. The company said Wednesday that under an agreement with DoctorDirectory.com Inc., its promotional partner...
|
|
|
MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx(R) Promotion for MOXATAG(R)
(BUSINESS WIRE) ----MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Company's promotion partner for MOXATAG (amoxicillin extended-release) Tablets, 775 mg, to...
|
|
|
MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx(R) Promotion for MOXATAG(R)
(BUSINESS WIRE) ----MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Company's promotion partner for MOXATAG (amoxicillin extended-release) Tablets, 775 mg, to...
|
|
|
MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx(R) Promotion for MOXATAG(R)
(BUSINESS WIRE) ----MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Company's promotion partner for MOXATAG (amoxicillin extended-release) Tablets, 775 mg, to...
|
|
|
MiddleBrook Pharmaceuticals, DoctorDirectory.com enter into agreement to expand IncreaseRx promotion program
MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Companys promotion partner for MOXATAG (amoxicillin extended-release) Tablets, 775 mg, to expand its previously...
|
|
|
MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx Promotion for MOXATAG
WESTLAKE, Texas - (Business Wire) MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Companys promotion partner for MOXATAG (amoxicillin extended-release) Tablets,...
|
|
|
MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx Promotion for MOXATAG
MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Companys promotion partner for MOXATAG (amoxicillin extended-release) Tablets, 775 mg, to expand its previously...
|
|
|
MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx(R) Promotion for MOXATAG(R)
Dave Becker, acting president and chief executive officer of MiddleBrook said, "Under this expanded IncreaseRx(R) program, physicians who previously received MOXATAG samples and information from MiddleBrook field sales representatives will be able to request...
|
|
|
MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx Promotion for MOXATAG
MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Company's promotion partner for MOXATAG (amoxicillin extended-release) Tablets, 775 mg, to expand its previously...
|
|
|
MiddleBrook Pharma (MBRK) Enters Agreement to Expand Previously Announced IncreaseRx(R) Promotion Program
MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK) today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Company's promotion partner for MOXATAG (amoxicillin extended-release) Tablets, 775 mg, to expand its previously...
|
|
|
Research and Markets: Lyme Disease - Drug Pipeline Analysis and Market Forecasts to 2016
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/a4bad0/lyme_disease_dru) has announced the addition of GlobalData 's new report "" to their offering.which provides the key data, information and analysis on the Lyme...
|
|
|
IDMA suggests compulsory purchase of Pen-G from domestic players as against anti dumping duty
The Indian Drug Manufacturers Association (IDMA) has suggested an alternative to the imposition of anti dumping duty on Penicillin-G imports from China, for which the proposition is under consideration of the Directorate General of Anti-Dumping & Allied...
|
|
|
TopAbstracts in H. Pylori/Ulcer 03/09/2010
TopAbstracts in H.Pylori/Ulcer are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 28 days. Over 2000 peer-reviewed journals are...
|
|
|
A Randomized Controlled Trial: Efficacy and Safety of Azithromycin, Ofloxacin, Bismuth, and Omeprazole Compared With Amoxicillin, Clarithromycin, Bismuth, and Omeprazole as Second-Line Therapy in Patients With Helicobacter pylori Infection
Jazi AHD et al.A Randomized Controlled Trial: Efficacy and Safety of Azithromycin, Ofloxacin, Bismuth, and Omeprazole Compared With Amoxicillin, Clarithromycin, Bismuth, and Omeprazole as Second-Line Therapy in Patients With Helicobacter ...
|
|
|
Amoxicillin drives resistance in child UTIs
GPs should avoid prescribing ampicillin to any child with a UTI who has been given amoxicillin at any time in the previous two months, say US researchers.Researchers evaluated the impact of previous antimicrobial exposure on the development of...
|
|
|
Xiantai got EGMP certificates for Amoxicillin and Ampicillin
_ Xiantai got EGMP certificates for Amoxicillin and Ampicillin.
|
|
|
Sequential Therapy Eradicates Helicobacter pylori Better Than Triple Therapy in Aklavik Natives: Presented at
my personal edition> h.pylori/ulcer > news E-Mail this DGDispatch to a colleague DGDispatch TORONTO -- March 2, 2010 -- Inuit people living in the far north of Canada have a prevalence of Helicobacter pylori 3 times that of the general...
|
|
|
Product news (6 March 2010)
SPCs for medicines are available online SPC changes Patients with the rare hereditary conditions fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltase insufficiency should not take Nystan (nystatin; Bristol-Myers Squibb) according to the...
|
|
|
Recent Amoxicillin Exposure Linked to Drug-Resistant UTIs in Children
Children exposed to amoxicillin within 60 days of a urinary tract infection (UTI Recent Amoxicillin Exposure Linked to Drug-Resistant UTIs in Children.
|
|
|
Recent Amoxicillin Exposure Linked to Drug-Resistant UTIs in Children
In order to use Medscape, your browser must be set to accept cookies delivered by the Medscape site.To find out how to adjust your browser settings to accept cookies, please click here. Medscape uses cookies to customize the site based on the information...
|
|
|
Recent amoxicillin exposure linked to drug-resistant UTIs in children
_ Recent amoxicillin exposure linked to drug-resistant UTIs in children.
|
|
|
Onbrez
ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia,...
|
|
|
Lotanos Comp
ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia,...
|
